(Q42675814)

English

Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain

scientific article published on April 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Russell K. Portenoy

1

object named as

Russell K Portenoy

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

Andréa Sciberras

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Lise Eliot

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Gordon Loewen

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Jackie Butler

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

John Devane

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Journal of Pain and Symptom Management

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

292-300

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Trends in medical use and abuse of opioid analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900382-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Opioid therapy for chronic nonmalignant pain: clinician's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900382-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900382-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900382-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900382-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Breakthrough pain: definition, prevalence and characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900382-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0885-3924(02)00382-2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42675814&oldid=2197119896"